Trials / Conditions / Recurrent Peritoneal Malignant Mesothelioma
Recurrent Peritoneal Malignant Mesothelioma
3 registered clinical trials studyying Recurrent Peritoneal Malignant Mesothelioma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors NCT03074513 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelio NCT02535312 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Active Not Recruiting | Pembrolizumab in Treating Patients With Malignant Mesothelioma NCT02399371 | University of Chicago | Phase 2 |